Protagonist Therapeutics (PTGX) Current Taxes (2018 - 2025)
Protagonist Therapeutics' (PTGX) quarterly Current Taxes came in at $1.9 million in Q1 2025, down 43.21% year-on-year from $3.3 million in Q1 2024, and down 29.75% quarter-over-quarter from $2.7 million in Q4 2024.
Protagonist Therapeutics (PTGX) Current Taxes (2018 - 2025) Analysis & Trends
Protagonist Therapeutics has disclosed Current Taxes across 3 years of filings, most recently posting $1.9 million for Q1 2025.
- Current Taxes for Q1 2025 came in at $1.9 million, down 43.21% year-over-year; the trailing twelve-month figure through Mar 2025 was $1.9 million (down 43.21% YoY), and the FY2024 annual result was $2.7 million, changed N/A from the prior year.
- Current Taxes came in at $1.9 million for Q1 2025 at Protagonist Therapeutics, down from $2.7 million in the prior quarter.
- In the past five years, Current Taxes ranged from a high of $3.3 million in Q1 2024 to a low of $1.0 million in Q3 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 10,460.56 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 19.20 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Protagonist Therapeutics | 7.35 Bn | 7.35 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 1.89 Mn |
| Dec 31, 2024 | 2.69 Mn |
| Sep 30, 2024 | 1.05 Mn |
| Jun 30, 2024 | 2.65 Mn |
| Mar 31, 2024 | 3.33 Mn |
| Jun 30, 2018 | 276,000.00 |
| Mar 31, 2018 | 379,000.00 |